Ebrahimi Azadeh, Honegger Juergen, Schluesener Hermann, Schittenhelm Jens
1Division of Immunopathology of the Nervous System.
Int J Surg Pathol. 2013 Dec;21(6):591-8. doi: 10.1177/1066896913486695. Epub 2013 May 6.
Craniopharyngioma is an epithelial tumor of the sellar region with a high survival rate but a high rate of recurrence, especially in children. Hypothalamic involvement, tumor recurrence, and multiple treatments result in clinical deterioration and impaired quality of life. Using immunohistochemistry, we investigated the expression pattern of osteonectin, a marker of tumor invasion and aggressive behavior, in 43 cases of craniopharyngioma. We observed a positive correlation of osteonectin expression in connective-type stromal tissue surrounding the epithelial tumor cells of craniopharyngioma with the extent of central nervous system infiltration and recurrence rate (P < .001). Given the previous success of chemotherapeutic agents that target the tumor microenvironment, our findings on osteonectin expression in stroma of craniopharyngiomas might, hopefully, be a guide to find newer prognostic markers capable of estimating the risk of progression or recurrence. They may also aid in the development of therapeutics that target tumor microenvironment to improve patient outcome.
颅咽管瘤是一种鞍区上皮性肿瘤,生存率高但复发率也高,尤其是在儿童中。下丘脑受累、肿瘤复发和多次治疗会导致临床病情恶化和生活质量受损。我们采用免疫组织化学方法,研究了骨连接蛋白(一种肿瘤侵袭和侵袭性行为标志物)在43例颅咽管瘤中的表达模式。我们观察到,颅咽管瘤上皮肿瘤细胞周围结缔组织型基质组织中骨连接蛋白的表达与中枢神经系统浸润程度和复发率呈正相关(P <.001)。鉴于此前针对肿瘤微环境的化疗药物取得了成功,我们关于颅咽管瘤基质中骨连接蛋白表达的研究结果有望成为寻找能够评估进展或复发风险的新预后标志物的指南。它们还可能有助于开发针对肿瘤微环境的治疗方法,以改善患者的预后。